Angiography follow up and intravascular imaging modality indicate optimal endovascular direction in femoropopliteal artery disease

Angiography follow up and intravascular imaging modality indicate optimal endovascular direction in femoropopliteal artery disease - Phalcon Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025204

Enrollment

400

Registered

2016-12-09

Start date

2016-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with agreement for study

Exclusion criteria

Exclusion criteria: 1 Patients without agreement for study 2 inappropriate patients determined from study director 3 patients within 20 years old 4 A life expectancy within 1 year 5 acute limb ischemia patients 6 inappropriate patients with contrast media usage

Design outcomes

Primary

Measure	Time frame
1Restenosis rate one year after endovascular treatment by angiography with QVA system 2Revascularization event with endovascular or surgical therapy within one year after endovascular treatment	—

Secondary

Measure	Time frame
1ABI(3,6,9,12months after endovascular treatment) 2Change of lower limb sympton 3Acute limb event 4Death, Myocardial Infarction, stroke event	—

Countries

Japan

Contacts

Public ContactMichiaki Higashitani

Tokyo Medical University Ibaraki Medical Center Department of Cardiology

mhigashi@tokyo-med.ac.jp029-887-1161

Outcome results